Capital International Investors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Capital International Investors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-33,700	Closed	-$4.14M	–	452
2020 Q2	$4.14M	Sell	33,700 -72,800	-68%	-$8.26M	﹤0.01%	392
2020 Q1	$9.33M	Hold	106,500	–	–	﹤0.01%	353
2019 Q4	$11.1M	Hold	106,500	–	–	﹤0.01%	350
2019 Q3	$12.3M	Sell	106,500 -124,140	-54%	-$18.8M	﹤0.01%	352
2019 Q2	$39.8M	Hold	230,640	–	–	0.02%	292
2019 Q1	$38.9M	Hold	230,640	–	–	0.02%	289
2018 Q4	$22.5M	Buy	230,640 +42,640	+23%	+$5.59M	0.01%	305
2018 Q3	$32.5M	Buy	+188,000	New	+$27.1M	0.01%	300

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Capital International Investors's GWPH Position: Q3 2020 in Review

Capital International Investors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 33,700 shares — an estimated $4.14M sold.

Capital International Investors first reported a position in GWPH in Q3 2018 and held it in 8 quarters. The position peaked at $39.8M in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Capital International Investors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Capital International Investors sold 33,700 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $4.14M.
Capital International Investors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 8 quarters.
Capital International Investors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $39.8M in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Capital International Investors's 13F filing for Q3 2020, filed 13 Nov 2020.